UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial

Circulation Journal, 2021/10/25, Vol.85(11), pp.1983-1990

2021

Volltextzugriff (PDF)

Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents

Current opinion in cardiology, 2020-11, Vol.35 (6), p.705

2020

Volltextzugriff (PDF)

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

JACC. Cardiovascular interventions, 2020-05, Vol.13 (9), p.1100-1109

2020

Volltextzugriff (PDF)

Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers

Journal of the American Heart Association, 2022-11, Vol.11 (22), p.e026041-e026041

2022

Volltextzugriff (PDF)

Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate

The Lancet (British edition), 2023-11, Vol.402 (10416), p.1942-1943

2023

Volltextzugriff (PDF)

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

The Lancet (British edition), 2018-10, Vol.392 (10154), p.1235-1245

2018

Volltextzugriff (PDF)

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT

JACC. Cardiovascular interventions, 2019-09, Vol.12 (17), p.1650-1660

2019

Volltextzugriff (PDF)

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents

JACC. Cardiovascular interventions, 2019-09, Vol.12 (17), p.1650-1660

2019

Volltextzugriff (PDF)

Final 5‐year report of BIONYX comparing the thin‐composite wire‐strut zotarolimus‐eluting stent versus ultrathin‐strut sirolimus‐eluting stent

Catheterization and cardiovascular interventions, 2024-07, Vol.104 (1), p.1-9

2024

Volltextzugriff (PDF)

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2018-10, Vol.14 (8), p.915

2018

Volltextzugriff (PDF)

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

Catheterization and cardiovascular interventions, 2020-11, Vol.96 (5), p.E508-E515

2020

Volltextzugriff (PDF)

Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial

Catheterization and cardiovascular interventions, 2021-08, Vol.98 (2), p.E188-E196

2021

Volltextzugriff (PDF)

New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials

The American heart journal, 2020-10, Vol.228, p.109-115

2020

Volltextzugriff (PDF)

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

International journal of cardiology, 2021-02, Vol.325, p.37-44

2021

Volltextzugriff (PDF)

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

Catheterization and cardiovascular interventions, 2020-08, Vol.96 (2), p.E110-E118

2020

Volltextzugriff (PDF)

Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-III

JACC. Cardiovascular interventions, 2020-04, Vol.13 (7), p.808-816

2020

Volltextzugriff (PDF)

Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms

Journal of personalized medicine, 2022-06, Vol.12 (6), p.990

2022

Volltextzugriff (PDF)

THREE-YEAR OUTCOME OF ALL-COMER PATIENTS TREATED WITH RESOLUTE ONYX ZOTAROLIMUS-ELUTING VERSUS ORSIRO SIROLIMUS-ELUTING STENTS IN THE RANDOMIZED BIONYX TRIAL

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.1026-1026

2021

Volltextzugriff (PDF)

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial

Circulation Journal, 2021/07/13, pp.CJ-21-0292

2021

Volltextzugriff (PDF)

Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents

JACC. Cardiovascular interventions, 2020-04, Vol.13 (7), p.808-816

2020

Volltextzugriff (PDF)

Superiority of biodegradable polymer sirolimus-eluting stents in STEMI

The Lancet (British edition), 2019-10, Vol.394 (10205), p.1208-1210

2019

Volltextzugriff (PDF)

TCT-518 Final 5-Year Report of the Randomized BIONYX Trial Assessing Onyx Versus Orsiro Drug-eluting Stents in All-Comers

Journal of the American College of Cardiology, 2023-10, Vol.82 (17), p.B209-B210

2023

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial

Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers

Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents

Final 5‐year report of BIONYX comparing the thin‐composite wire‐strut zotarolimus‐eluting stent versus ultrathin‐strut sirolimus‐eluting stent

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial

New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-III

Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms

THREE-YEAR OUTCOME OF ALL-COMER PATIENTS TREATED WITH RESOLUTE ONYX ZOTAROLIMUS-ELUTING VERSUS ORSIRO SIROLIMUS-ELUTING STENTS IN THE RANDOMIZED BIONYX TRIAL

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial

Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents

Superiority of biodegradable polymer sirolimus-eluting stents in STEMI

TCT-518 Final 5-Year Report of the Randomized BIONYX Trial Assessing Onyx Versus Orsiro Drug-eluting Stents in All-Comers

Suchergebnisse filtern